Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment
Open Access
- 20 July 2022
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (9) , 2424-2432
Abstract
Context J-DISCOVER is a prospective observational cohort study aiming to understand the current management of patients with early-stage type 2 diabetes mellitus (T2DM) in Japan, enrolling patients initiating second-line treatment. Objective The current analysis examined the change in treatment satisfaction during the study period and factors affecting this change among patients in J-DISCOVER. Methods We used data from the J-DISCOVER study, in which 1798 patients with T2DM aged ≥ 20 years were enrolled from 142 sites across Japan. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Results The mean DTSQ treatment satisfaction score increased from 25.9 points at baseline to 27.3 points at 6 months, which was maintained through 36 months. Among the baseline characteristics examined, higher baseline DTSQ treatment satisfaction scores (P < 0.0001), older age (≥ 75 vs < 65 years, P = 0.0096), living alone (P = 0.0356), and type of facility (clinics vs hospitals, P = 0.0044) had a significantly negative impact on the changes in DTSQ treatment satisfaction scores. Improvement in mean glycated hemoglobin (HbA1c) from baseline (7.7%) to 36 months (7.1%) was associated with positive changes in the DTSQ treatment satisfaction score (P = 0.0003). Conclusion Changes in DTSQ treatment satisfaction scores were related to HbA1c improvement, suggesting that the management strategy was appropriately planned for each patient. The results also suggest that the availability of social support for patients with T2DM who are elderly or living alone may be an important factor affecting treatment satisfaction, adherence, and clinical outcomes.Keywords
Funding Information
- AstraZeneca K.K.
- Ono Pharmaceutical Co., Ltd
This publication has 31 references indexed in Scilit:
- Hypoglycemia: The neglected complicationIndian Journal of Endocrinology and Metabolism, 2013
- A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Preference and Adherence, 2012
- Correlates of Quality of Life in Older Adults With DiabetesDiabetes Care, 2011
- A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetesCurrent Medical Research and Opinion, 2011
- Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 DiabetesDiabetes Care, 2011
- Factors that Affect Medication Adherence in Elderly Patients with Diabetes MellitusKorean Diabetes Journal, 2010
- Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily1Diabetic Medicine, 2009
- Treatment satisfaction of diabetic patients: what are the contributing factors?Family Practice, 2009
- Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetesNutrition, Metabolism and Cardiovascular Diseases, 2009
- Patient perceptions of diabetes and diabetes therapy: assessing quality of lifeDiabetes/Metabolism Research and Reviews, 2002